A Scottish drug discovery business has announced that they will soon be able to complete 15,000 COVID-19 diagnostic tests per month in a bid to help the country combat the virus.
Censo Biotechnologies will repurpose its laboratories in Scotland and Cambridge to process a minimum of 500 diagnostic tests every day. The tests will enable the NHS to test their staff and tell anxious patients whether or not they are suffering from the virus.
The initiative will support a request from Health Secretary Matt Hancock, who today urged the UK life sciences industry to mobilise behind his plan to complete 100,000 tests by the end of April.
Censo has the capacity to rise to his challenge because of a recent injection of funds from their principal investor, Par Equity, an Edinburgh-based venture capital firm that specialises in high tech businesses.
Read more HERE.
